| Strength | 150 mg |
| Brand | Ibyra |
| Tablets per Pack | 60 Tablets |
| Usage | Pancreatic Cancer, Ovarian Cancer, Breast Cancer |
| Form | Tablet |
| Pack Type | Bottle |
| Composition | Olaparib |
Minimum order quantity: 10 Box
Ibyra Olaparib 150mg Tablet
Product IntroductionIbyra 150mg Tablet is a prescription medicine used in the treatment of ovarian and breast cancer. It works by blocking an enzyme called PARP, which helps fix damaged DNA. By stopping PARP, the medicine prevents cancer cells from repairing themselves, leading them to die off and slowing tumor growth.
Ibyra 150mg Tablet may be taken with or without food. Swallow the tablets whole, without crushing, chewing, or splitting them. Take it regularly and at the same time every day to maintain an even level of the medication in your body. Follow your doctor’s instructions on the exact dosage and schedule.
Common side effects include nausea, fatigue, vomiting, loss of appetite, diarrhea, and dizziness. If you experience nausea or vomiting, eating smaller, more frequent meals and staying hydrated can help. Inform your doctor if these side effects become severe or do not go away. Be cautious about driving or operating heavy machinery if you feel dizzy or fatigued.
While taking Ibyra 150mg Tablet, avoid consuming grapefruit or grapefruit juice as it can increase the risk of side effects. This medicine can cause harm to an unborn baby, so it is important to use effective contraception during treatment and for some time after the last dose. Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Uses of Ibyra TabletTreatment of Breast cancerTreatment of Ovarian cancer
Benefits of Ibyra TabletIn Treatment of Breast cancerIbyra 150mg Tablet provides a targeted treatment option that specifically attacks cancer cells while sparing most healthy cells. Clinical studies have shown that Ibyra 150mg Tablet can significantly reduce the risk of cancer progression or recurrence and improve survival rates. By specifically inhibiting the PARP enzyme in cancer cells, Ibyra 150mg Tablet helps to slow the spread of the disease, providing patients with a more effective and less toxic treatment option.
Side effects of Ibyra TabletMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of IbyraNauseaVomitingFatigueDiarrheaLoss of appetiteAnemiaHeadacheDecreased blood cells Taste changeCoughBreathlessnessIndigestionAbdominal pain
How to use Ibyra TabletTake this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ibyra 150mg Tablet may be taken with or without food.
How Ibyra Tablet worksIbyra 150mg Tablet is an anticancer medication. It works by inhibiting the growth of select tumor cell lines in vitro and decrease tumor growth in both as monotherapy or following chemotherapy.
Safety adviceAlcoholIt is not known whether it is safe to consume alcohol with Ibyra 150mg Tablet. Please consult your doctor.
PregnancyIbyra 150mg Tablet is not recommended during pregnancy as there is positive evidence of fetal risk based on animal studies. However, it may still be prescribed by a doctor in situations where the benefits outweigh the risks.
Breast feedingIbyra 150mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
DrivingIbyra 150mg Tablet may decrease alertness, affect your vision, or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
KidneyIbyra 150mg Tablet is safe to use in patients with kidney disease. No dose adjustment is recommended.
LiverIbyra 150mg Tablet is safe to use in patients with liver disease. No dose adjustment is recommended.